Year All2023202220212020201920182017201620152014 KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update Nov 13, 2023 KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Sep 20, 2023 KALA BIO to Present at H.C. Wainwright 25th Annual Global Investment Conference Sep 05, 2023 KALA BIO Reports Second Quarter 2023 Financial Results and Provides Corporate Update Aug 04, 2023 KALA BIO to Participate in Upcoming Investor Conferences in August Aug 02, 2023 Kala Pharmaceuticals Announces Name Change to KALA BIO Aug 02, 2023 Kala Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Jul 19, 2023 Kala Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Jun 23, 2023 Kala Pharmaceuticals to Present at the Jefferies Healthcare Conference Jun 02, 2023 Kala Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update May 09, 2023
Kala Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update May 09, 2023